Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Analgesic Stories

2014-04-15 16:28:26

SAN DIEGO, April 15, 2014 /PRNewswire/ -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced that the U.S. District Court in Massachusetts entered an order, preventing the implementation of the Commonwealth's ban of Zohydro(TM) ER on Constitutional grounds. This order will become effective on April 22, 2014. The court decision today supports the...

2014-04-12 23:02:07

Topical pain relief creams such as Lidocream, Ketocream, Indocream, and Gabacream are introduced and described. Los Angeles, CA (PRWEB) April 12, 2014 Well-known compounding pharmacist and entrepreneur in Beverly Hills, Dr. Hootan Melamed, has introduced a range of proven and effective formulated creams that are designed to provide relief from inflammation and pain. In many cases, mass produced medications may not be able to provide adequate relief or may cause side effects in certain...

2014-04-08 23:29:14

“Cobrazol,” a no-smell roll on anti-inflammatory gel, was featured on NewsWatch as part of its popular segment, HealthWatch, which took a look at the latest medical products and services available to consumers. Susan Bridges, the host of NewsWatch and a medical expert, conducted the product review and shared with viewers how it treats chronic pain without the side effects of an ingested drug. Washington, DC (PRWEB) April 08, 2014 “Cobrazol”, a no-smell roll on anti-inflammatory...

2014-04-08 20:21:36

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the U.S. Food and Drug Administration (FDA)-approved prescription drug product, Zohydro(TM) ER (hydrocodone bitartrate) extended-release capsules (CII), entered on March 27, 2014, by Massachusetts Governor Deval Patrick. Zogenix appreciates the opportunity to be heard by the court on an expedited basis. A follow-up hearing has been...

2014-04-04 08:25:20

SAN DIEGO, April 4, 2014 /PRNewswire/ -- Today, Health and Human Services (HHS) Secretary Kathleen Sebelius, and U.S. Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg, called for a balanced approach in the fight against prescription drug abuse and preserving the protection of the needs and rights of patients suffering from severe chronic pain. It was an impressive showcase of a unified front and a call for all stakeholders to help at every level. It is vitally important...

2014-04-03 12:28:34

MUMBAI, India, April 3, 2014 /PRNewswire/ -- - GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1 - The molecule has successfully completed pre-clinical and Phase 1 enabling studies. Regulatory submission has been filed for Phase 1 trial (first-in-human) with MHRA, UK - mPGES-1 inhibitors selectively block the production of PGE2 while sparing other prostanoids of physiological importance...

2014-03-30 23:21:56

Alternative solutions and medications to replace harsh prescription drugs recommend by Pharmacist Dr. Hootan Melamed Los Angeles, CA (PRWEB) March 30, 2014 Renowned Beverly Hills compounding pharmacist and entrepreneur, Dr. Hootan Melamed, is committed to the goal of providing innovative solutions to address the concerns of patients suffering from myriad problems. Dr. Melamed recommends a range of highly effective and proven non-invasive products that are designed to ease the side effects...

2014-03-26 08:23:34

Management to Detail the Commercialization of High Value Pain Products including Oxycodone using its TPM® Topical Drug Delivery Technology MELBOURNE, Australia, March 26, 2014 /PRNewswire/ --Phosphagenics Limited (ASX: POH) (OTCQX: PPGNY) ("Phosphagenics" or "the Company") announced today that management will host an investor conference call and webcast to discuss the commercial opportunities arising from a range of innovative analgesic products emerging from the Company's...

2014-03-07 08:26:19

Two-thirds of states include methadone on preferred drug lists for Medicaid patients PHOENIX, March 7, 2014 /PRNewswire-USNewswire/ -- Two-thirds of states prefer methadone above other opioid medications to treat chronic pain, particularly in low-income residents, a practice top pain physicians say adds unnecessary risk. Physician leaders from the American Academy of Pain Medicine (AAPM) released a position paper today to warn all states and private insurers that methadone should...

2014-03-06 20:21:55

Researchers sought comprehensive predictors of opioid abuse in veterans based on discontinuation rates PHOENIX, March 6, 2014 /PRNewswire-USNewswire/ -- Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30(th) Annual Meeting of the American Academy of Pain Medicine reported on a number of factors associated with opioid discontinuation with...